Does TAFAMIDIS Cause Ventricular hypertrophy? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Ventricular hypertrophy have been filed in association with TAFAMIDIS (Vyndamax). This represents 0.1% of all adverse event reports for TAFAMIDIS.
6
Reports of Ventricular hypertrophy with TAFAMIDIS
0.1%
of all TAFAMIDIS reports
1
Deaths
0
Hospitalizations
How Dangerous Is Ventricular hypertrophy From TAFAMIDIS?
Of the 6 reports, 1 (16.7%) resulted in death.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TAFAMIDIS Cause?
Death (2,553)
Dyspnoea (608)
Off label use (571)
Cardiac failure (444)
Fatigue (438)
Fall (372)
Malaise (301)
Hypoacusis (298)
Atrial fibrillation (296)
Asthenia (256)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which TAFAMIDIS Alternatives Have Lower Ventricular hypertrophy Risk?
TAFAMIDIS vs TAFAMIDIS MEGLUMINE
TAFAMIDIS vs TAFASITAMAB
TAFAMIDIS vs TAFASITAMAB-CXIX
TAFAMIDIS vs TAFINLAR
TAFAMIDIS vs TAFLUPROST